Ghisallo Capital Management LLC increased its holdings in Bowhead Specialty Holdings Inc. (NYSE:BOW – Free Report) by 41.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 120,000 shares of the company’s stock after buying an additional 35,000 shares during the quarter. Ghisallo Capital Management LLC owned about 0.37% of Bowhead Specialty worth $4,262,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in the business. Charles Schwab Investment Management Inc. grew its stake in shares of Bowhead Specialty by 18.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 77,337 shares of the company’s stock worth $2,747,000 after purchasing an additional 12,049 shares in the last quarter. Geode Capital Management LLC bought a new position in Bowhead Specialty in the 3rd quarter valued at about $4,691,000. Barclays PLC acquired a new position in Bowhead Specialty during the 3rd quarter valued at about $479,000. JPMorgan Chase & Co. raised its position in shares of Bowhead Specialty by 102.4% during the 4th quarter. JPMorgan Chase & Co. now owns 99,813 shares of the company’s stock worth $3,545,000 after buying an additional 50,491 shares in the last quarter. Finally, Gallatin Point Capital LLC bought a new stake in shares of Bowhead Specialty during the 4th quarter worth about $389,599,000.
Insiders Place Their Bets
In other news, Director Ava Schnidman bought 1,493 shares of the company’s stock in a transaction dated Friday, February 28th. The shares were acquired at an average cost of $33.41 per share, with a total value of $49,881.13. Following the completion of the transaction, the director now directly owns 1,893 shares in the company, valued at approximately $63,245.13. The trade was a 373.25 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Bowhead Specialty Stock Down 3.3 %
Bowhead Specialty (NYSE:BOW – Get Free Report) last announced its earnings results on Tuesday, February 25th. The company reported $0.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.07. The company had revenue of $184.77 million for the quarter, compared to analyst estimates of $102.12 million. On average, equities analysts anticipate that Bowhead Specialty Holdings Inc. will post 1.36 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of research analysts recently commented on the stock. Keefe, Bruyette & Woods lowered their price objective on shares of Bowhead Specialty from $44.00 to $43.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 9th. JPMorgan Chase & Co. lifted their price target on Bowhead Specialty from $30.00 to $35.00 and gave the company a “neutral” rating in a research report on Tuesday, April 8th. Piper Sandler initiated coverage on Bowhead Specialty in a research note on Wednesday, April 16th. They issued an “overweight” rating and a $44.00 price objective on the stock. Finally, JMP Securities raised their target price on Bowhead Specialty from $38.00 to $40.00 and gave the company a “market outperform” rating in a research note on Friday, April 11th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $37.17.
Get Our Latest Stock Report on BOW
Bowhead Specialty Company Profile
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Featured Articles
- Five stocks we like better than Bowhead Specialty
- The Risks of Owning Bonds
- Short Sellers Gave Up on These 3 Names Recently
- Stock Analyst Ratings and Canadian Analyst Ratings
- 3 Boring Stocks Outperforming the Market This Year
- Insider Trading – What You Need to Know
- If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy
Receive News & Ratings for Bowhead Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bowhead Specialty and related companies with MarketBeat.com's FREE daily email newsletter.